Results 11 to 20 of about 20,685,408 (374)

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. [PDF]

open access: yesJournal of molecular medicine, 2016
Apolipoprotein (apo) E was initially described as a lipid transport protein and major ligand for low density lipoprotein (LDL) receptors with a role in cholesterol metabolism and cardiovascular disease.
Mahley, Robert W
core   +2 more sources

Apolipoprotein E and Alzheimer’s disease: The influence of apolipoprotein E on amyloid- and other amyloidogenic proteins [PDF]

open access: yesJournal of Lipid Research, 2017
Alzheimer’s disease (AD) is one of the fastest-growing causes of death and disability in persons 65 years of age or older, affecting more than 5 million Americans alone.
Agosta   +207 more
core   +3 more sources

Apolipoprotein E in lipid metabolism and neurodegenerative disease.

open access: yesTrends in endocrinology and metabolism, 2023
Dysregulation of lipid metabolism has emerged as a central component of many neurodegenerative diseases. Variants of the lipid transport protein, apolipoprotein E (APOE), modulate risk and resilience in several neurodegenerative diseases including late ...
Linda G. Yang   +3 more
semanticscholar   +1 more source

Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy

open access: yesMolecular Psychiatry, 2022
Allelic variation to the APOE gene confers the greatest genetic risk for sporadic Alzheimer’s disease (AD). Independent of genotype, low abundance of apolipoprotein E (apoE), is characteristic of AD CSF, and predicts cognitive decline.
A. Belaidi   +13 more
semanticscholar   +1 more source

Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1

open access: yesCancer Research, 2021
This study shows that elevated apolipoprotein E in PDAC mediates immune suppression and high serum apolipoprotein E levels correlate with poor patient survival. Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with few effective therapeutic
Samantha B. Kemp   +17 more
semanticscholar   +1 more source

Apolipoprotein E and Alzheimer's disease

open access: yesActa Pharmaceutica Sinica B, 2021
Genetic variation in apolipoprotein E (APOE) influences Alzheimer's disease (AD) risk. APOE ε4 alleles are the strongest genetic risk factor for late onset sporadic AD.
B. Troutwine   +4 more
semanticscholar   +1 more source

Apolipoprotein E is secreted by cultured lipocytes of the rat liver.

open access: yesJournal of Lipid Research, 1991
Hepatic lipocytes, the retinoid-storing cells of the liver, share several characteristics with vascular smooth muscle cells. To determine whether they also share the characteristic of apolipoprotein E secretion, we have compared the relative mRNA ...
G Friedman   +3 more
doaj   +1 more source

Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia

open access: yesAnnals of General Psychiatry, 2021
Background The apolipoprotein E (ApoE) gene polymorphisms are correlated with blood lipid levels and several neuropsychiatric symptoms. Therefore, this study aimed to examine whether the ApoE rs429358 affected the development and clinical symptoms of ...
Wenwang Rao   +4 more
doaj   +1 more source

Apolipoprotein E related Co-Morbidities and Alzheimer’s disease [PDF]

open access: yes, 2016
The primary goal of advancement in clinical services is to provide a health care system that enhances an individual’s quality of life. Incidence of diabetes mellitus, cardiovascular disease and associated dementia coupled with the advancing age of the ...
Akiyama   +147 more
core   +1 more source

Home - About - Disclaimer - Privacy